Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Biodexa Pharmaceuticals plc American Depositary Shs (BDRX)

https://www.biodexapharma.com

Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and development medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/07/2015

Market Cap

139,087

Shares Outstanding

96,680,000

Weighted SO

2,619,516

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

Beta

1.4700

Last Div

0.0000

Range

0.554-9.64

Chg

0.0035

Avg Vol

3782303

Mkt Cap

139087

Exch

NASDAQ

Country

GB

Phone

44 29 2048 0180

DCF Diff

2.1117

DCF

-1.0417

Div Yield

0.0000

P/S

0.2821

EV Multiple

0.8361

P/FV

0.1337

Div Yield %

0.0000

P/E

-0.0884

PEG

-0.0009

Payout

0.0000

Current Ratio

1.2623

Quick Ratio

1.3888

Cash Ratio

1.0722

DSO

674.4357

DIO

-57.0769

Op Cycle

617.3588

DPO

25.4576

CCC

591.9013

Gross Margin

-10.8163

Op Margin

-17.3333

Pretax Margin

-19.6457

Net Margin

-18.5801

Eff Tax Rate

-0.0542

ROA

-0.6715

ROE

-1.4190

ROCE

-1.3280

NI/EBT

0.9458

EBT/EBIT

1.1334

EBIT/Rev

-17.3333

Debt Ratio

0.0440

D/E

0.0992

LT Debt/Cap

0.0593

Total Debt/Cap

0.0902

Int Coverage

0.0000

CF/Debt

-14.7112

Equity Multi

2.2535

Rec Turnover

0.5412

Pay Turnover

14.3376

Inv Turnover

-6.3949

FA Turnover

0.6673

Asset Turnover

0.0361

OCF/Share

-5.1274

FCF/Share

-5.1470

Cash/Share

4.4852

OCF/Sales

-17.9160

FCF/OCF

1.0038

CF Coverage

-14.7112

ST Coverage

-40.3905

CapEx Coverage

-262.5385

Div&CapEx Cov

-262.5385

P/BV

0.1337

P/B

0.1337

P/S

0.2821

P/E

-0.0884

P/FCF

-0.0157

P/OCF

-0.0917

P/CF

-0.0917

PEG

-0.0009

P/S

0.2821

EV Multiple

0.8361

P/FV

0.1337

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 22, 08:30 Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024 GlobeNewswire Inc. Dec 29, 04:05 Biodexa Appoints Ann Merchant to the Board of Directors Benzinga Dec 19, 13:34 Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Benzinga Dec 19, 12:54 Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results GlobeNewswire Inc. Dec 19, 08:42 Biodexa Announces Pricing of $5.2 Million Underwritten Public Offering Benzinga Nov 27, 13:41 Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Revenue Product Segmentation